Codonopsis pilosula-containing pharmaceutical composition for lowering blood fat

A composition and technology of Codonopsis pilosula, applied in the field of blood lipid-lowering pharmaceutical compositions, can solve the problems of overly large prescriptions, unfavorable promotion and application, and high prices

Inactive Publication Date: 2015-02-25
CHENGDU GUORUI PHARMA TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are many Chinese patent medicines for the treatment of hyperlipidemia, some of which have too large prescriptions and unclear curative effects, and some are quite expensive due to the use of precious medicinal materials in the prescriptions
These make it unfavorable to promote the price application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The blood lipid-lowering pharmaceutical composition described in the present embodiment is made of the following raw materials:

[0033] Codonopsis 12g, Atractylodes macrocephala 8g, holly hair 6g, jujube 6g, plantain seed 6g, kelp 6g, cicada slough 3g and evening primrose 12g.

[0034] The above-mentioned raw materials are prepared into granules, and the preparation method is as follows:

[0035] Add 9 times the volume of 70% ethanol to the raw materials in the above weight ratio, reflux extraction three times, the extraction time is 2.0h, 1.5h, 1.5h respectively, filter, combine the filtrates for 3 times, recover the ethanol and concentrate, and then concentrate each Mix the liquid evenly, dry, then add 150g sucrose, make granules according to the preparation technology of granules, and pack into bags.

Embodiment 2

[0037] The blood lipid-lowering pharmaceutical composition described in this embodiment is made of the following raw materials:

[0038] Codonopsis 5g, Atractylodes macrocephala 4g, Maodongqing 2g, jujube 1g, plantain seed 2g, kelp 1g, cicada slough 1g and evening primrose 7g.

[0039] The above-mentioned raw materials are prepared into tablets, and the preparation method is as follows:

[0040] Add 10 times the volume of 70% ethanol to the raw materials in the above weight ratio, reflux and extract three times, the extraction time is 2.0h, 1.5h, 1.5h respectively, filter, combine the filtrates for 3 times, recover the ethanol and concentrate, and then concentrate each The mixture is uniformly mixed, dried, then mixed with 120 g of starch and 15 g of povidone, and is prepared into a pharmaceutical composition of tablets by using existing tabletting technology.

Embodiment 3

[0042] The blood lipid-lowering pharmaceutical composition described in this embodiment is made of the following raw materials:

[0043] Codonopsis 20g, Atractylodes macrocephala 15g, holly hair 9g, jujube 7g, plantago 9g, kelp 10g, cicada slough 6g and evening primrose 18g.

[0044] Above-mentioned raw material is prepared into powder, and preparation method is as follows:

[0045] Add 9 times the volume of 60% ethanol to the raw materials in the above weight ratio, reflux extraction three times, the extraction time is 2.0h, 1.5h, 1.5h respectively, filter, combine the filtrates for 3 times, recover the ethanol and concentrate, and then concentrate each Liquid mixed evenly, dried, then mixed with 150g dextrin, made into powder according to the preparation technology of powder, and packed into bags.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a codonopsis pilosula-containing pharmaceutical composition for lowering blood fat. The pharmaceutical composition is prepared from codonopsis pilosula, atractylodes macrocephala, ilex pubescens, Chinese dates, plantain seeds, laminaria, cicada slough and oenothera biennis. Proofed by pharmacological experiments, the pharmaceutical composition disclosed by the invention has a very good blood fat lowering effect, is definite in treatment effect, low in drug dosage and simple in prescription, is free from toxic or side effects on human bodies and is beneficial to popularization and application.

Description

technical field [0001] The invention relates to a drug composition for lowering blood fat, in particular to a drug composition made from Codonopsis pilosula, Atractylodes macrocephala, Radix Ilex, Jujube, Plantago seed, kelp, cicada slough and evening primrose. Background technique [0002] With the continuous improvement of people's living standards, the incidence of hyperlipidemia is on the rise, and hyperlipidemia is the cause of coronary atherosclerotic heart disease (coronary heart disease), arteriosclerosis, fatty liver, diabetes, obesity important factors of disease. Therefore, it is of great practical significance to find efficient and non-toxic blood lipid-lowering drugs. [0003] Lipoproteins refer to proteins combined with lipids, including very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). The lipid composition of different lipoproteins is mainly quantitative different, less qualitatively different. 80% t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/725A61P3/06
CPCA61K36/344A61K9/14A61K9/1623A61K9/2059A61K9/4858A61K36/03A61K36/185A61K36/284A61K36/68A61K36/725A61K2300/00
Inventor 骆均勇李文军张太君
Owner CHENGDU GUORUI PHARMA TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap